Documentos de Académico
Documentos de Profesional
Documentos de Cultura
100p
50p
0p
Jan-09
Jul-09
Jan-10
Jul-10
Source: Bloomberg
Richard Savage
+44 (0) 20 7866 0098
richard.savage@mirabaud.co.uk
Tim Hurst-Brown
Source: Mirabaud Securities.
+44 (0) 20 7866 0092
tim.hurst.brown@mirabaud.co.uk
The news of a further successful test result from Bijeel-1 is, of course, positive for Gulf Keystone.
Alex Martinos However, this well, which took around a year to drill and test, was targeting a relatively small
+44 (0) 20 7866 0212 structure. Moreover, the find lies within Akri Bijeel, where Gulf Keystone has the lowest equity
alex.martinos@mirabaud.co.uk
exposure (12.8% fully diluted) out of its four Kurdistan blocks. For the moment, our NAV for the
Oil & Gas Sales Bijeel discovery remains unchanged at 2p/shr (on the basis of a 75% CoS; 150 mmbbls gross
Pav Sanghera recoverable), pending the outcome of further appraisal work.
+44 (0) 20 7878 3380
pav.sanghera@mirabaud.co.uk In our view, the real action lies elsewhere. Firstly, there are two much larger prospective
structures located in the block: Bekhme to the East and Bakrman (renamed Aqra in the latest
Harry Baker
+44 (0) 20 7878 3401
presentation) to the West. These feature abundant surface oil seeps (see Figure 2, below).
harry.baker@mirabaud.co.uk Initially MOL chose to drill the smaller Bijeel structure because it feared the oil seeps equated to
seal risk – success at Shaikan suggests otherwise. In its own announcement today, Gulf Keystone
Resources Sales Trading
said it believed the Bijeel discovery could possibly be the southern flank of the Bekhme structure
Lucas McHugh – the company hopes that MOL will spud a well on Bekhme in Q1 2011. At present we value
+44 (0) 20 7866 0085
lucas.mchugh@mirabaud.co.uk Bekhme at 14p/shr (unrisked), based on 1 bn bbls gross recoverable resources.
MIRABAUD Securities LLP 33, Grosvenor Place London SW1X 7HY, UK T +44 (0)20 7321 2508 F +44 (0)20 7930 4066
www.mirabaudsecurities.co.uk
Figure 2: Oil seeps, Akri Bijeel Block
Accelerating activity
In the meantime, the belated completion of testing at Bijeel-1 allows for the
mobilisation of the Weatherford 842 rig to the location prepared for the delayed
Shaikan-2 well. This deep appraisal well has been designed to test the flank of the
Shaikan discovery, with the aim of proving the lateral extent of the good quality
reservoir seen at Shaikan-1, as well as exploring deeper horizons that proved beyond
the reach of the discovery well, due to the unexpected high gas pressures
encountered in the Triassic formation.
Elsewhere, activity continues apace – something we were able to witness on a site
visit last week. Drilling operations are proceeding at the Shaikan-3 shallow appraisal
well, while the Sheikh Adi-1 exploration well has now reached a depth of over 900
metres with oil shows visible, although progress has not been helped by the total loss
of drilling fluids into the highly fractured cretaceous interval. The company has made
progress in its quest for a fourth rig and hopes to spud the Shaikan-4 well in Q1 2011.
This will be the second deep appraisal well to be drilled on the discovery, located at a
prepared site at the Western end of the licence towards the Sheikh Adi block.
Figure 3: Seismic acquisition, Shaikan Block
MIRABAUD Securities LLP 33, Grosvenor Place London SW1X 7HY, UK T +44 (0)20 7321 2508 F +44 (0)20 7930 4066
www.mirabaudsecurities.co.uk 2
3D seismic acquisition operations are now nearing completion on the Shaikan block,
and ongoing over the Sheikh Adi licence. The Shaikan-1 early production facilities are
complete, with pipelines, separator, storage and offloading equipment all
operational. At present, having sent samples for assessment at local refineries, the
company is in the process of negotiating a sales contract. With this in place, extended
production testing will resume, with management estimating that rates of 8,000-
10,000 bopd can be achieved.
Figure 4: Production facilities, Shaikan block
Gulf Keystone’s shares have enjoyed a good run, and with a market cap of c.£1.45bn,
the stock is, in our view, now approaching fair value. However, there are plenty more
valuation drivers to energise the share price over the coming 6-9 months. In addition
to the accelerating pace of activity on the ground, likely to bring further drilling
results, we also anticipate a domestic crude sales agreement and initial results from
the 3D seismic shoot. In the background, there is the added possibility of positive
political developments in Iraq, while there has also been an influx of big
independents (notably Marathon Oil and most recently Murphy Oil) into the Kurdistan
region. These factors together are likely to maintain share price momentum; however,
with one eye on valuation, we are lowering our recommendation from BUY to
ACCUMULATE on an unchanged 200p/shr target price.
MIRABAUD Securities LLP 33, Grosvenor Place London SW1X 7HY, UK T +44 (0)20 7321 2508 F +44 (0)20 7930 4066
www.mirabaudsecurities.co.uk 3
RECOMMENDATIONS HISTORY
RATINGS SYSTEM
BUY: The stock is expected to generate absolute positive price performance of over 20% during the next 12 months.
ACCUMULATE: The stock is expected to generate absolute positive price performance of 10-20% during the next 12 months
NEUTRAL: The stock is expected to generate absolute price performance of between 10% positive and 10% negative
during the next 12 months.
REDUCE: The stock is expected to generate absolute negative price performance of 10-20% during the next 12 months
SELL: The stock is expected to generate absolute negative price performance of over 20% during the next 12
months.
Stocks bear significantly higher risk that typically cannot be valued by normal fundamental criteria. Investments in the stock may
result in material loss.
All research is issued under the regulatory oversight of Mirabaud Securities LLP
Each Investment Analyst of Mirabaud Securities LLP whose name appears as the Author of this Investment Research hereby
certifies that the recommendations and opinions expressed in the Investment Research accurately reflect the Investment Analyst's
personal, independent and objective views about any and all of the Designated Investments or Relevant Issuers discussed herein
that are within such Investment Analyst's coverage universe.
INVESTMENT RESEARCH DISCLOSURES
The following disclosures relate to this document: 2,8
DISCLAIMER
ISSUED BY MIRABAUD SECURITIES LLP, A COMPANY AUTHORISED AND REGULATED BY THE FINANCIAL
SERVICES AUTHORITY. A MEMBER OF THE LONDON STOCK EXCHANGE
© Mirabaud Securities LLP. All rights reserved. Any unauthorised use or distribution is strictly prohibited. This document has been
prepared and issued by Mirabaud Securities LLP or its associated companies and has been approved for publication in the United
Kingdom by Mirabaud Securities LLP, a limited liability partnership authorised and regulated by the Financial Services Authority. This
document is distributed in Hong Kong by Mirabaud Securities (Asia) Limited, which is authorised as a licensed dealer in securities and
regulated by the Hong Kong Securities and Futures Commission. Neither the information nor the opinions expressed in this document
constitute or intend to be an offer, or a solicitation of an offer, to buy or sell relevant securities (i.e. securities mentioned herein and
options, warrants, or rights to or interests in any such securities). The information and opinions contained in this document have been
compiled from and based upon generally available information which Mirabaud Securities LLP believes to be reliable but the accuracy or
completeness of which cannot be guaranteed. All comments and estimates given are statements of Mirabaud Securities LLP’s or an
associated company’s opinion only and no express or implied representation or warranty is given or to be implied therefrom. All opinions
expressed herein are subject to change without notice. This document does not take into account the specific investment objectives,
financial status, attitude to risk or any other specific matters relevant to any person who receives this document and should therefore not
be used in substitution for the exercise of judgment by such person. Neither Mirabaud Securities LLP nor any associated company accepts
any liability whatsoever for any direct or consequential loss arising from the use of its advice or research publications save where such loss
arises as a direct result of Mirabaud Securities LLP’s or an associated company’s negligence. Research publications are issued by Mirabaud
Securities LLP or an associated company for private circulation to eligible counterparties, professional clients and professional advisers,
(“its clients”), and specifically not to private or retail clients. They may not be reproduced, distributed or published by you for any purpose
except with Mirabaud Securities LLP’s express written permission. Mirabaud Securities LLP, an associated company, or their employees
and officers may have a holding (long or short) in an investment which it knows will be the subject of a published research
recommendation to clients. It may also have a consulting relationship with a company being reported on. Mirabaud Securities LLP or an
associated company may also act as agent of its clients and may have or have undertaken transactions in investments covered by this
document prior to your receipt of it.